Adverum Stock Future Price Prediction


USD 0.68  0.03  4.23%   

Adverum Biotechnlgs stock price prediction is an act of determining the future value of Adverum Biotechnlgs shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Adverum Biotechnlgs' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Adverum Biotechnlgs and does not consider all of the tangible or intangible factors available from Adverum Biotechnlgs' fundamental data. We analyze noise-free headlines and recent hype associated with Adverum Biotechnlgs, which may create opportunities for some arbitrage if properly timed.
Please continue to Adverum Biotechnlgs Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Adverum Biotechnlgs based on different types of headlines from major news networks to social media. The Adverum stock price prediction module provides an analysis of price elasticity to changes in media outlook on Adverum Biotechnlgs over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Adverum Biotechnlgs hype-based prediction, you can estimate the value of Adverum Biotechnlgs from the perspective of Adverum Biotechnlgs response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Adverum Biotechnlgs using Adverum Biotechnlgs' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Adverum using crowd psychology based on the activity and movement of Adverum Biotechnlgs' stock price.
Adverum Biotechnlgs Quick Ratio is relatively stable at the moment as compared to the past year. The company's current value of Quick Ratio is estimated at 19.70. Asset Turnover is expected to hike to 0.0192 this year, although the value of Cash Flow Per Share will most likely fall to (1.18) .

Adverum Biotechnlgs Short Interest

A significant increase or decrease in Adverum Biotechnlgs' short interest from the previous month could be a good indicator of investor sentiment towards Adverum. Short interest can provide insight into the potential direction of Adverum Biotechnlgs stock and how bullish or bearish investors feel about the market overall. An investor who is long Adverum Biotechnlgs may also wish to track short interest. As short interest increases, investors should be becoming more worried about Adverum Biotechnlgs and may potentially protect profits, hedge Adverum Biotechnlgs with its derivative instruments, or be ready for some potential downside.
200 Day MA
Short Percent
Short Ratio
Shares Short Prior Month
2.6 M
50 Day MA
Shares Short
2.4 M

Adverum Biotechnlgs Hype to Price Pattern

Investor biases related to Adverum Biotechnlgs' public news can be used to forecast risks associated with investment in Adverum. The trend in average sentiment can be used to explain how an investor holding Adverum can time the market purely based on public headlines and social activities around Adverum Biotechnlgs. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Adverum Biotechnlgs' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Adverum Biotechnlgs.

Adverum Biotechnlgs Implied Volatility

Adverum Biotechnlgs' implied volatility exposes the market's sentiment of Adverum Biotechnlgs stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Adverum Biotechnlgs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Adverum Biotechnlgs stock will not fluctuate a lot when Adverum Biotechnlgs' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Adverum Biotechnlgs. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Adverum Biotechnlgs to buy its stock at a price that has no basis in reality. In that case, they are not buying Adverum because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Adverum Biotechnlgs after-hype prediction price

  $ 0.72  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Adverum Biotechnlgs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Adverum Biotechnlgs in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
5 Analysts
LowTarget PriceHigh
Estimates (4)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Adverum Biotechnlgs. Your research has to be compared to or analyzed against Adverum Biotechnlgs' peers to derive any actionable benefits. When done correctly, Adverum Biotechnlgs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Adverum Biotechnlgs.

Adverum Biotechnlgs After-Hype Price Prediction Density Analysis

As far as predicting the price of Adverum Biotechnlgs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adverum Biotechnlgs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adverum Biotechnlgs, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Adverum Biotechnlgs Estimiated After-Hype Price Volatility

In the context of predicting Adverum Biotechnlgs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adverum Biotechnlgs' historical news coverage. Adverum Biotechnlgs' after-hype downside and upside margins for the prediction period are 0.04 and 4.77, respectively. We have considered Adverum Biotechnlgs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.68
After-hype Price
Adverum Biotechnlgs is dangerous asset. Analysis and calculation of next after-hype price of Adverum Biotechnlgs is based on 3 months time horizon.

Adverum Biotechnlgs Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Adverum Biotechnlgs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adverum Biotechnlgs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adverum Biotechnlgs, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.82  4.07  0.02   1.26  1 Events / Month1 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Adverum Biotechnlgs Hype Timeline

Adverum Biotechnlgs is presently traded for 0.68. The entity has historical hype elasticity of 0.02 and average elasticity to hype of competition of 1.26. Adverum is anticipated to increase in value after the next headline with the price projected to jump to 0.72 or above. The average volatility of media hype impact on the company stock price is over 100%. The price surge on the next news is forecasted to be 2.86% whereas the daily expected return is presently at -0.82%. The volatility of related hype on Adverum Biotechnlgs is about 265.43% with expected price after next announcement by competition of 1.94. The company currently holds 105.48 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Given the investment horizon of 90 days the next anticipated press release will be very soon.
Please continue to Adverum Biotechnlgs Basic Forecasting Models to cross-verify your projections.

Adverum Biotechnlgs Related Hype Analysis

Having access to credible news sources related to Adverum Biotechnlgs' direct competition is more important than ever and may enhance your ability to predict Adverum Biotechnlgs' future price movements. Getting to know how Adverum Biotechnlgs rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adverum Biotechnlgs may potentially react to the hype associated with one of its peers.

Adverum Biotechnlgs Additional Predictive Modules

Most predictive techniques to examine Adverum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adverum using various technical indicators. When you analyze Adverum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Adverum Biotechnlgs Predictive Indicators

The successful prediction of Adverum Biotechnlgs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adverum Biotechnlgs, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adverum Biotechnlgs based on analysis of Adverum Biotechnlgs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adverum Biotechnlgs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adverum Biotechnlgs's related companies.
 2020 2021 2022 (projected)
PPandE Turnover0.250.280.29
Long Term Debt to Equity0.06040.06950.0997

Story Coverage note for Adverum Biotechnlgs

The number of cover stories for Adverum Biotechnlgs depends on current market conditions and Adverum Biotechnlgs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adverum Biotechnlgs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adverum Biotechnlgs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Adverum Biotechnlgs Short Properties

Adverum Biotechnlgs' future price predictability will typically decrease when Adverum Biotechnlgs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adverum Biotechnlgs often depends not only on the future outlook of the potential Adverum Biotechnlgs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adverum Biotechnlgs' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.66%
Short Percent Of Float3.03%
Float Shares85.24M
Shares Short Prior Month2.47M
Average Daily Volume Last 10 Day1.08M
Average Daily Volume In Three Month521.69k
Date Short Interest14th of October 2022
Please continue to Adverum Biotechnlgs Basic Forecasting Models to cross-verify your projections. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for analysis

When running Adverum Biotechnlgs price analysis, check to measure Adverum Biotechnlgs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnlgs is operating at the current time. Most of Adverum Biotechnlgs' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnlgs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adverum Biotechnlgs' price. Additionally, you may evaluate how the addition of Adverum Biotechnlgs to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Adverum Biotechnlgs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnlgs. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnlgs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
70.9 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Adverum Biotechnlgs is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnlgs' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnlgs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnlgs' market value can be influenced by many factors that don't directly affect Adverum Biotechnlgs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnlgs' value and its price as these two are different measures arrived at by different means. Investors typically determine Adverum Biotechnlgs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnlgs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.